IP Archives of Cytology and Histopathology Research
Official Publication of Khyati Education and Research Foundation
Official Publication of Khyati Education and Research Foundation
Print ISSN: 2581-5725
Online ISSN: 2456-9267
CODEN : IACHCL
IP Archives of Cytology and Histopathology Research (ACHR) open access, peer-reviewed quarterly journal publishing since 2016 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing the article more...Case Report
Author Details :
Volume : 9, Issue : 1, Year : 2024
Article Page : 53-55
https://doi.org/10.18231/j.achr.2024.010
Abstract
T cell histiocytes rich large cell lymphoma (THRLBCL) is rare variant of DLBCL and characterised by predominantly reactive cell and a few atypical B cells. It has an aggressive clinical course and can metastasise to different organ. Due to presence of reactive T cells and histiocytes, it can be misdiagnosed as reactive lymphadenitis. Ancillary technique like immunohistochemistry can help in diagnosing this entity. We describe a case of T cell histiocyte rich large B cell lymphoma presenting as suppurative lymphadenitis which is a rare presentation.
Keywords: Rare, Aggressive, Reactive cells, Biopsy, Immunohistochemistry, DLBCL
How to cite : Agarwal L, Bishnoi A, Jain R, Saxena R, T cell histiocyte rich large B cell lymphoma presenting as suppurative lymphadenitis causing a diagnostic pitfall. IP Arch Cytol Histopathol Res 2024;9(1):53-55
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
